Literature DB >> 10357026

Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

S N Ghaemi1, G S Sachs, A M Chiou, A K Pandurangi, K Goodwin.   

Abstract

BACKGROUND: Previous studies have suggested that bipolar disorder may be underdiagnosed, and that antidepressants may be over-utilized in its treatment.
METHODS: Consecutively admitted patients (n =48) diagnosed with DSM-IV bipolar disorder, type I, (n = 44) or schizoaffective disorder, bipolar type, (n = 4) were interviewed systematically and their charts were reviewed to confirm diagnosis before admission. They were then treated according to systematic structured interview diagnoses. These data reflect the changes in diagnoses and treatment.
RESULTS: 40% (19/48) were identified with previously undiagnosed bipolar disorder, all previously diagnosed with unipolar major depressive disorder. A period of 7.5+/-9.8 years elapsed in this group before bipolar diagnosis was made. Antidepressant use was high on admission (38%) and was reduced with acceptable treatment response rates. The adjunctive use of risperidone appeared to be a good treatment alternative. LIMITATIONS: While diagnoses were made prospectively, treatment response was assessed retrospectively, and was based on non-randomized, naturalistic therapy.
CONCLUSIONS: Systematic application of DSM-IV criteria identified previously undiagnosed bipolar disorder in 40% of a referred population of patients with mood disorders, all previously misdiagnosed as unipolar major depressive disorder. Antidepressants appeared overutilized and risperidone was an effective alternative adjunctive therapy agent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357026     DOI: 10.1016/s0165-0327(98)00076-7

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  67 in total

1.  Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.

Authors:  K Gao; D E Kemp; C Conroy; S J Ganocy; R L Findling; J R Calabrese
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

2.  Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder.

Authors:  Melissa M Jenkins; Eric A Youngstrom; Jennifer Kogos Youngstrom; Norah C Feeny; Robert L Findling
Journal:  Psychol Assess       Date:  2011-10-17

3.  Misdiagnosis of bipolar disorder.

Authors:  Tanvir Singh; Muhammad Rajput
Journal:  Psychiatry (Edgmont)       Date:  2006-10

Review 4.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

5.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

6.  Bipolar-I depression outpatient treatment quality and costs in usual care practice.

Authors:  Alisa B Busch; Richard G Frank; Gary Sachs
Journal:  Psychopharmacol Bull       Date:  2008

Review 7.  Prospective: Is bipolar disorder being overdiagnosed?

Authors:  Tammas Kelly
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

8.  Hypomanic symptoms in female undergraduate students diagnosed with unipolar depression based on scores on the hypomania checklist.

Authors:  Thomas Richardson; Hugh Garavan
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-12-18

9.  Current nosology of treatment resistant depression: a controversy resistant to revision.

Authors:  Michele Fornaro; Patricia Giosuè
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-05-04

10.  Polarity of the first episode and time to diagnosis of bipolar I disorder.

Authors:  Boseok Cha; Jeong Hyun Kim; Tae Hyon Ha; Jae Seung Chang; Kyooseob Ha
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.